[Federal Register Volume 62, Number 36 (Monday, February 24, 1997)]
[Notices]
[Pages 8255-8256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4486]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute on Drug Abuse (NIDA) Initial Review Group and 
Special Emphasis Panel meetings.

    Purpose/Agenda: To review and evaluate grant applications.
    Name of Committee: Health Service Research Subcommittee.
    Date: March 4-5, 1997.
    Time: 8:30 a.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Raquel Crider, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-9042.

    Name of Committee: Treatment Research Subcommittee.
    Date: March 4-6, 1997.
    Time: 8:30 a.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Kesinee Nimit, M.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-9042.

    Name of Committee: NIDA Special Emphasis Panel (Treatment).

[[Page 8256]]

    Date: March 5, 1997.
    Time: 1:00 p.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Rita Liu, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-2620.

    This notice is being published less than 15 days prior to the 
meetings due to the urgent need to meet timing limitations imposed 
by the review and funding cycle.

    Name of Committee: AIDS Behavioral Research Subcommittee.
    Date: March 10-11, 1997.
    Time: 8:30 a.m.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: William C. Grace, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-9042.

    Name of Committee: Aids Biomedical and Clinical Research 
Subcommittee.
    Date: March 18-19, 1997.
    Time: 8:30 a.m.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Gamil Debbas, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-2620.

    Name of Committee: NIDA Special Emphasis Panel (Centers).
    Date: March 18-19, 1997.
    Time: 8:00 a.m.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: Mary C. Custer, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-2620.

    Name of Committee: NIDA Special Emphasis Panel (SBIRs).
    Date: March 20-21, 1997.
    Time: 8:30 a.m.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Mary C. Custer, Ph.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-2620.

    Name of Committee: NIDA Special Emphasis Panel (RFA DA-97-002--
Neurobiological Effects of Drug Abuse Therapies).
    Date: March 24-25, 1997.
    Time: 8:30 a.m.
    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Kesinee Nimit, M.D., Scientific Review 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone 
(301) 443-9042.

    The meetings will be closed in accordance with provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.. The 
applications and the discussions could reveal confidential trade 
secrets or commercial property such as patentable material and 
personal information concerning individuals associated with the 
applications, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.277, 
Drug Abuse Research Scientist Development and Research Scientist 
Awards: 93.278, Drug Abuse National Research Service Awards for 
Research Training; 93.279, Drug Abuse Research Programs.)

    Dated: February 18, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-4486 Filed 2-21-97; 8:45 am]
BILLING CODE 4140-01-M